Results 241 to 250 of about 266,260 (301)

Data‐Independent Acquisition Mass Spectrometry in Tumor Classification and Cancer Biomarker Research

Mass Spectrometry Reviews, EarlyView.
Abstract Cancer treatment is far from optimal also because current classification systems do not reflect the complex molecular status of the tumor and its phenotype in sufficient detail. To construct molecular tumor classifiers, omics tools provide complex molecular data reflecting many aspects from genotype to phenotype.
Jan Simonik, Petr Lapcik, Pavla Bouchalova, Pavel Bouchal   +3 more
wiley   +1 more source

Risk factors analysis and nomogram model construction of refeeding syndrome after esophageal cancer surgery. [PDF]

Front Oncol
Shi Y, Liu X, Wang Y, Zhou Y, Gu J, Li Y, Li K, Wang S, Ni Y.   +8 more
europepmc   +1 more source

The Expanding Landscape of Microbiota Medicine: Indications, Therapeutic Modalities, and the Path Towards Integrative Microbiome‐Targeting Healthcare

Microbiota Medicine Research, EarlyView.
ABSTRACT The growing recognition of the microbiome's role in human health has propelled the emergence of microbiota medicine—a new discipline integrating microbiology, multi‐omics, and clinical science. Advances in sequencing, data integration, and interventions such as fecal microbiota transplantation (FMT) have transitioned the field from ...
Min Dai, Yisha Lin, Renyou Gan, Xiaotao Shen, Shin Young Park, Sunjae Lee, Qi Su   +6 more
wiley   +1 more source

Correction: NIR-responsive Cu2−xSe@Fc nanoparticles for photothermal- ferroptosis combination therapy in esophageal cancer

Journal of Nanobiotechnology
Linlin Shi, Ying Yu, Jiayi Li, Beng Ma, Xiaoman Zhang, Pingjuan Yang, Pan Chen, Zhifeng Qu, Fengqi Zhang, Ke Liu, Shegan Gao, Haoyan Cheng   +11 more
doaj   +1 more source

Mapping research trends in esophageal cancer immunotherapy: A decade of thematic evolution and emerging priorities. [PDF]

Hum Vaccin Immunother
Jia H, Gong Y, Zhao C, Wei H, Zang Q.
europepmc   +1 more source

Best evidence for the prevention and management of anastomotic fistula after esophagectomy in patients with esophageal cancer. [PDF]

Asia Pac J Oncol Nurs
Liu Q, Chen X, Hong Y, Liu D.
europepmc   +1 more source

Phase II randomized trial of 41.4 Gy vs. 50.4 Gy in neoadjuvant chemoradiotherapy for resectable esophageal cancer. [PDF]

Clin Transl Radiat Oncol
Esmati E, Nazari R, Aqamolaei A, Maddah Safaei A, Miri R, Shirkhoda M, Jalaeefar A, Salarvand S, Aghili M, Farhan F, Mousavi Darzikolaee N, Kolahdouzan K, Abyaneh R, Ghalehtaki R.   +13 more
europepmc   +1 more source

Construction of a preoperative prehabilitation program for elderly esophageal cancer patients. [PDF]

Front Oncol
Chen X, Zhou K, Cai F, Liu Z, Luo C, Shao X.   +5 more
europepmc   +1 more source

Identification of a Novel Disulfidptosis-Related Five-Gene Signature for Prognostic Prediction and Immune Characterization in Esophageal Cancer. [PDF]

Biology (Basel)
Chen Y, Li X, Jiang H, Liu X, Ma N, Wang X.   +5 more
europepmc   +1 more source